Olix Pharmaceuticals, Inc. Stock Price & Chart

KRX: 226950 · 올릭스 · KOSPI

₩113,700▲ ₩4,200 (+3.84%)at close · July 27, 2026
217,00035,000113,700Jul 03, 25Oct 10Jan 14Apr 20Jul 27, 26

Olix Pharmaceuticals, Inc. (올릭스, KRX: 226950) last closed at ₩113,700 on July 27, 2026, a +3.84% move on the day. Over the trailing 52 weeks the stock has traded between ₩36,350 and ₩217,000, a +193.42% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩113,700
Day change+3.84%
52-week high₩217,000
52-week low₩36,350

Key Fundamentals

FY 2026.03
Market cap₩2.39T
P/E (PER)-141.47
P/B (PBR)16.87
EPS₩-774
BPS₩6,738
ROE-14.41%
Debt ratio28.17%
Rev. growth265.80%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-27
BearishAlgorithmic summary of 5 standard indicators (net score -5). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 130,760
  • ▼ Bearish60-day MAPrice below 144,853
  • ▼ Bearish120-day MAPrice below 155,698
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 38 — neutral zone
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 43% of rangeRSI(14): 385-day volume vs 20-day: -25%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning Olix Pharmaceuticals, Inc.

No daily reports have covered Olix Pharmaceuticals, Inc. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.